Yifei Yin
Chaigoubu, 223002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
BCAR3 Hypomethylation as a Potential Diagnostic Marker for Thyroid Cancer and Its Mechanism via Promoting EMT and AKT/mTOR Pathway.
Journal: Cancers
Published: October 13, 2025
Discovery and validation of PARP4 methylation in distinguishing thyroid cancer from benign nodule.
Journal: Journal of endocrinological investigation
Published: June 07, 2025
FABP3 methylation as a novel biomarker for the differentiation and classification of benign and malignant thyroid nodules.
Journal: Frontiers in endocrinology
Published: May 16, 2025
Panel Testing of BRAF Mutation, RAS Mutation, and RET/PTC Rearrangements or RET Mutation Using Fine-Needle Aspiration Specimens in Evaluation of Thyroid Carcinoma.
Journal: Diagnostic cytopathology
Published: March 12, 2025
RASGEF1C methylation for the distinguishment and classification of benign and malignant thyroid tumors.
Journal: Clinical epigenetics
Published: December 14, 2024
IL21R hypomethylation as a biomarker for distinguishing benign and malignant breast tumours.
Journal: Epigenetics
Published: May 09, 2024
DNA Methylation Status of HYAL1 in Malignant and Benign Thyroid Nodules.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: December 01, 2023
RPTOR methylation in the peripheral blood and breast cancer in the Chinese population.
Journal: Genes & genomics
Published: August 16, 2021
Showing 1-10 of 10
Last Updated: 09/26/2026